"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market Towards Substantial Growth"

According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.

It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like illness and, in some cases, lead to life-threatening complications. According to the World Health Organization (WHO), dengue is a significant public health concern, with an estimated 390 million infections per year worldwide.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://www.alliedmarketresearch.com/request-toc-and-sample/4101

However, as mentioned, there are also some factors that are currently restraining the market growth, such as low awareness in emerging nations and high underdiagnosis rates. Dengue is prevalent in many developing countries, where healthcare infrastructure and access to diagnostic tests may be limited. In addition, many cases of dengue fever are asymptomatic or have mild symptoms, which can make it challenging to diagnose accurately.

Despite these challenges, there are several opportunities for the market growth in the future. One such opportunity is the rising awareness about the symptoms of dengue fever among the general public, which can help in early detection and diagnosis of the infection. Moreover, many governments and healthcare organizations are taking initiatives to improve healthcare facilities and access to diagnostic tests, especially in developing countries.

Key Market Players
𝐀𝐫𝐤𝐫𝐚𝐲 𝐈𝐧𝐜., 𝐂𝐞𝐫𝐞𝐬 𝐍𝐚𝐧𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐈𝐧𝐜., 𝐑𝐨𝐜𝐡𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥, 𝐂𝐨𝐫𝐠𝐞𝐧𝐢𝐱 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐫𝐩, 𝐅𝐊 𝐁𝐢𝐨𝐭𝐞𝐜𝐧𝐨𝐥𝐨𝐠𝐢𝐚 𝐒𝐀, 𝐐𝐮𝐚𝐧𝐭𝐮𝐌𝐃𝐱 𝐆𝐫𝐨𝐮𝐩 𝐋𝐭𝐝., 𝐒𝐚𝐧𝐬𝐮𝐫𝐞 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐈𝐧𝐜., 𝐐𝐮𝐢𝐝𝐞𝐥 𝐂𝐨𝐫𝐩, 𝐖𝐡𝐢𝐝𝐢𝐚𝐠 𝐒𝐀𝐒, 𝐏𝐢𝐜𝐭𝐨𝐫 𝐋𝐭𝐝.

Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.alliedmarketresearch.com/purchase-enquiry/4101

 𝐃𝐞𝐧𝐠𝐮𝐞 𝐕𝐢𝐫𝐮𝐬 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

By type, the market can be divided into Rapid Molecular Assay, Biomarker Assay, IsoAmp Assay, and Others. Rapid molecular assay is a type of diagnostic test that uses molecular techniques to detect the presence of dengue virus RNA in a patient's blood. Biomarker assay involves the measurement of certain proteins or other substances in the blood that are indicative of dengue virus infection. IsoAmp assay is a newer technology that uses isothermal amplification to detect the presence of dengue virus RNA. Other types of diagnostic tests may include enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and serological tests.

By end-user, the market can be classified into hospitals and research institutes. Hospitals are the primary end-users of dengue virus diagnostic tests, as they are responsible for diagnosing and treating patients with dengue fever. Research institutes may also use diagnostic tests to study the epidemiology and pathogenesis of dengue virus infection.

By region, the market can be segmented into North America, Europe, Asia-Pacific, and LAMEA. North America includes the United States, Canada, and Mexico. Europe includes France, Germany, Italy, Spain, the UK, and the rest of Europe. Asia-Pacific includes China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific. LAMEA includes Brazil, South Africa, Saudi Arabia, and the rest of LAMEA.

𝐁𝐮𝐲 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐃𝐞𝐧𝐠𝐮𝐞 𝐕𝐢𝐫𝐮𝐬 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 https://www.alliedmarketresearch.com/checkout-final/d811f7acedbc9c0e222af9b87522dd7a

𝐁𝐫𝐨𝐰𝐬𝐞 𝐨𝐭𝐡𝐞𝐫 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 :

Digital Diabetes Management Market https://www.alliedmarketresearch.com/digital-diabetes-management-market-A06052

Surgical Lights market https://www.alliedmarketresearch.com/surgical-lights-market-A06076

Pharmaceutical Drug Delivery Market https://www.alliedmarketresearch.com/pharmaceutical-drug-delivery-market-A06102

VR In Healthcare Market https://www.alliedmarketresearch.com/vr-in-healthcare-market-A06193

Infection Control Market https://www.alliedmarketresearch.com/infection-control-market-A07453

Laboratory Filtration Market https://www.alliedmarketresearch.com/laboratory-filtration-market-A08423

Microcatheters Market https://www.alliedmarketresearch.com/microcatheters-market-A10218

Mortuary Equipment Market https://www.alliedmarketresearch.com/mortuary-equipment-market-A10456

Spirometer Market https://www.alliedmarketresearch.com/spirometer-market-A10602

Cellulite Treatment Market https://www.alliedmarketresearch.com/cellulite-treatment-market-A10923

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.